India says firms can't raise low prices to match price caps

03/24/2013 | Economic Times (India), The

Firms selling drugs below government-mandated ceilings may not raise their prices, according to India's upcoming drug pricing policy. The decision addresses the concerns of the World Health Organization and health care providers that setting a market-based ceiling would trigger broad price increases. At present, 74 bulk drugs or active pharmaceutical ingredients are subject to price caps, as are 348 essential or live-saving drugs.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY